PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of dementneuroLink to Publisher's site
 
Dement Neuropsychol. 2010 Jan-Mar; 4(1): 23–27.
PMCID: PMC5619526

Language: English | Portuguese

Effects of intrahippocampal administration of the phosphatase inhibitor okadaic acid: Dual effects on memory formation

Efeitos da administração intra-hipocampal do inibidor de fosfatases ácido okadaico: efeito duplo sobre a formação de memória

Abstract

Protein phosphorylation mediated by serine-threonine kinases in the hippocampus is crucial to the synaptic modifications believed to underlie memory formation. The role of phosphatases has been the focus of comparatively little study.

Objectives

Here we evaluate the contribution of the serine-threonine protein phosphatases 1 and 2A (PP1, PP2A) on memory consolidation.

Methods

We used immediate post-training bilateral hippocampal infusions of okadaic acid (OA, 0.01 and 10 pmol/side), a potent inhibitor of PP1 and PP2A, and measured short- [3 h] and long-term memory [24 h] (STM, LTM) of step-down inhibitory avoidance.

Results

At the lower dose, OA inhibited both STM and LTM whereas at the higher dose it instead enhanced LTM. Pre-test infusion of these two doses of OA had no effect on retrieval.

Conclusions

These two doses of OA are known to selectively inhibit PP1 and PP2A respectively. These findings point to the importance of these enzymes in memory formation and also suggest a deleterious influence of endogenous hippocampal PP2A on LTM formation.

Keywords: hippocampus, PP1, PP2A, okadaic acid, short-term memory, long-term memory

Abstract

A fosforilação de proteínas mediada por serina-treonina quinases no hipocampo é crucial para as modificações sinápticas que se acredita sejam necessárias para a formação de memórias. O papel das fosfatases tem sido comparativamente pouco estudado.

Objetivos

Aqui avaliamos a contribuição das fosfatases serina-treonina 1 e 2 (PP1, PP2A) sobre a consolidação da memória.

Métodos

Usamos infusões imediatamente após o treino de ácido okadaico (OA, 0.01 e 10 pmol/lado), um potente inibidor de PP1 e medimos memória de curta [3 h] e longa duração [24 h] (STM, LTM) de esquiva inibitória de evitar descer de uma plataforma.

Resultados

Na dose menor, OA inibiu tanto STM como LTM. Na dose maior, produziu, em vez disso, uma melhora da LTM. A infusão pré-teste de qualquer uma das duas doses de OA não teve efeito sobre a evocação.

Conclusões

Estas duas doses de OA são conhecidas por inibir seletivamente PP1 a PP2 respectivamente. Estes resultados apontam à importância das duas enzimas na formação de memória e sugerem, adicionalmente, uma influência deletérea da PP2A endógena sobre a formação de LTM.

Several serine-threonine protein kinases constitute signaling pathways whose activation is necessary for memory formation in the hippocampus.1,2 These include the calcium-calmodulin dependent kinase [CaMKII] that mediates GluR1 phosphorylation,3,4 the cAMP-dependent [PKA] and mitogen-activated kinases [MAPK] that mediate phosphorylation of the transcription factor CREB and other substrates,5-7 and the calcium-dependent protein kinase family (PKC) that also mediates the phosphorylation of many substrates, including presynaptic proteins involved in glutamate release.8,9 There is abundant cross-talk among all these kinase families.7,10 Their importance in memory suggests that serine-threonine phosphatases such as PP1, PP2A and calcineurin may also play a role.11-14 Indeed, inhibitors of PP1 and PP2A enhance NMDA currents in cultured hippocampal neurons,15 but antagonize the NMDA receptor-dependent inhibition of late-long term potentiation (LTP) caused by low frequency stimulation in hippocampal slices.16 Both hippocampal early NMDA currents and late LTP appear to be necessary for memory formation.2,17,18 Inhibitors of PP1, PP2A and calcineurin have been shown to have deleterious effects on various forms of memory.11-13.19-21 The best studied of these phosphatases is calcineurin, for which an allosteric model has been suggested in which, once bound to calmodulin, calcineurin competes with CaMKII for calcium.14 Calcineurin appears to govern both an intermediate phase of LTP between the so-called early and late phases,22 and the development of LTM for spatial and nonspatial tasks.23 The inducible and reversible genetic inhibition of calcineurin in mouse brain enhances learning, STM and LTM of hippocampus-dependent tasks and hippocampal LTP in a PKA-dependent manner.24

The influence of PP1 and PP2A on memory variables is less clear. Genetic inhibition of PP1 suppresses the deleterious effect of massed trials on learning, and prolongs memory duration.25 Suppression also decreases LTD and favors LTP in a frequency-dependent manner in the hippocampus.26 While these findings are important and point to a role of PP1 both in hippocampal plasticity and memory parameters, they are not illustrative, however, as to what specific phase of memory PP1 is involved in. No similar data are available for PP2A. Although some of the behavioral findings do suggest a different time course for the PP1 and PP2A influences on memory,21 it is not clear whether different forms of memory are affected by each. We have recently demonstrated a degree of independence of short-term memory lasting 3 h or less (STM) and long-term memory lasting one day or more (LTM), which are essentially parallel processes.27,28

Here we concentrate on the inhibition of hippocampal PP1 and PP2A by two widely differing dose concentrations of okadaic acid well known to selectively inhibit one or the other enzyme.21,29,30 We studied one-trial inhibitory avoidance in rats, a task equivalent to the one-trial peck avoidance task studied in the one-day-old chick by Bennett, Ng and their coworkers,11,12.19,21 which is also acquired in a few seconds and, in the rat, depends mainly on the hippocampus2. In addition, it is the task in which STM and LTM were shown to be functionally separate27 and where LTM was found to use the same molecular cascades as LTP.2,18

Methods

Adult 3 month-old Wistar male rats (250-300 g) purchased from Fundação Estadual de Produção e Pesquisa em Saúde do Rio Grande do Sul, Porto Alegre were used. The animals were housed 5 to a cage and had free access to food and water under a 12/12 h light/dark cycle, with lights on at 7:00 AM. The temperature of the animal room was maintained at 22-24°C. To implant them with indwelling cannulae, rats were deeply anesthetized with thiopental (i.p., 30-50 mg/kg) and 27-gauge cannulae stereotaxically aimed at the CA1 region of the dorsal hippocampus, in accordance with coordinates (A ±4.3, L ±3.0, V 3.4) from the atlas of Paxinos and Watson.31 Animals were allowed to recover from surgery for 4 days before submitting them to any other procedure.

At the time of drug delivery, 30-gauge infusion cannulae were tightly fitted into the guides. Infusions (0.5 µl/side) were carried out over a 60 s period and the cannulae were left in place for 60 additional seconds to minimize backflow. The placement of the cannulae was verified postmortem: 2-4 h after the last behavioral test, 0.8 µl of a 4% methylene-blue solution was infused as described above and the spread of the dye 30 min thereafter was taken as an indication of the presumable diffusion of the vehicle or drug previously given to each animal. Only data from animals with correct cannulae implants were analyzed. All procedures were conducted in accordance with the ‘Principles of laboratory animal care’ (NIH publication No. 85-23, revised). After recovery from surgery, animals were trained in step-down inhibitory avoidance as described in detail elsewhere4,27 and immediately after training2-5,27 (Figure 1), or 5 min prior to testing 24 h later (Figure 2), they were infused bilaterally with 0.5 µl of 0.01, 1 or 10 pmoles of OA (Calbiochem) or its vehicle (20% dimetylsulfoxide). This lowest dose of OA is known to selectively inhibit PP1; intermediate doses do not affect the activity of any known phosphatase, while the highest dose of OA selectively inhibits PP2A.21,29,30 The infusion cannulae was fitted into the guide, its tip protruded 1 mm beyond that of the guide, and reached the CA1 region. Animals were tested for STM and LTM at 3h and 24h after training, respectively,27 and their latency to step-down from the platform onto the floor grid was measured automatically. Upon placing their four paws on the grid they received a 0.4 mA, 2 sec scrambled footshock on the training session. No footshocks were delivered during the STM or LTM test sessions.3-5,27 As is customary,2-5.27,28 the posttraining infusions were used to study drug effects on STM and/or LTM consolidation, and the pre-test infusions were used to study drug effects on retrieval.

Figure 1
Effect of bilateral intrahippocampal infusions of OA at different concentrations (0.01, 1 and 10 pmol/side) immediately after step-down inhibitory avoidance training session. Control group received vehicle (20% dimethylsulfoxide in saline) in which OA ...
Figure 2
Effect of bilateral intrahippocampal infusions of OA on memory retrieval when given 15 min before test session. Control group received vehicle (20% dimethylsulfoxide in saline) in which Okadaic acid was diluted. Treated animals received Okadaic at 1 and ...

To identify any unspecific side effects of the treatments on locomotor or exploratory activity we examined the effect of the doses of okadaic acid that significantly influenced memory on performance in an open-field task. The animals’ capacity of habituation to the novel environment (a 50 cm high, 50 cm wide and 39 cm deep open-field made of plywood painted white), and their locomotion and rearing was measured during a 5-min session. Locomotion was evaluated by counting crossings of black lines drawn on the floor of the cbox that divided it into 12 equal rectangles. In order to detect habituation performance of crossings and rearings in the first half of the session (2.5 min), these were compared to performances during the second half of the session.33 Habituation was measured as a significant decrease in both responses during the two halves of the session.

Only behavioral data from animals with correct cannulae placement was included in the final statistical analysis (Kruskal Wallis test followed by Mann Whitney for comparison among groups), as confirmed by histological control of cannulae placement.

Results

As shown in Figure 1, the intrahippocampal administration of 0.01 pmol of okadaic acid per side caused full amnesia for both STM and LTM on the inhibitory avoidance task. The 1 pmol dose was not effective and, surprisingly, the 10 pmol/side dose had a positive effect on LTM retention.

In addition, as shown in Figure 2, the two doses of okadaic acid that affected consolidation of the avoidance task had no effect on retrieval when given 5 min prior to the STM or the LTM test.

Table 1 illustrates that none of the treatments affected locomotion or exploration or their habituation in a 5 min open field session.

Table 1
Effect of intrahippocampal infusion of okadaic acid at doses that efficiently affected inhibitory avoidance memory (0.01 and 10 pmol/side) on crossings and rearings in the open field. Animals received bilateral infusions of vehicle (20% dimethylsulfoxide ...

Discussion

The amnestic effect of OA on both STM and LTM corroborate previous findings of acute and chronic treatments with OA involving various tasks and species.12,19.21,33 At a dose known to selectively inhibit PP1 (0.01 pmol/side),21,29,30 post-training intrahippocampal OA depressed both STM and LTM. At a dose known to selectively inhibit PP2A but not PP1 (10 pmol/side),21,29,30 post-training hippocampal OA specifically enhanced LTM consolidation.2,28 At an intermediate dose (1 pmol) which does not inhibit either enzyme,29,30 OA had no effect on either of the two forms of memory. Whether administered at the lower or at the higher dose, intrahippocampal OA given prior to retention testing had no effect on retrieval.

PP1 and PP2A interact with, and modulate, several intracellular signaling pathways known to influence LTD, LTP and LTM consolidation.13-16.22,23 The present findings provide no clues as to what specific system(s) participate in the amnesic influence of OA at the lower dose, or the mechanisms underlying the enhancing effect on LTM at the highest dose. Nevertheless, the latter phenomenon clearly points to an inhibitory role of endogenous PP2A in LTM consolidation.

Phosphatases, in particular calcineurin and PP1,25 have been suggested to act as inhibitory constraints to memory formation25 and, alternatively, to represent mechanisms of active forgetting.34 Although the evidence available does not allow us to determine which is the most accurate of these descriptions, both hypotheses reinforce the well-known complexity of the cognitive processes and point to phosphatases as important factors. The importance of a degree of forgetting34,35 in order to establish new or important memories has been recently studied in detail,35 including its implications in terms of catabolic biochemical processes.36 It is possible that the enhancement of LTM formation by OA, at the dose that inhibits PP2A, may be related to this forgetting activity.

Footnotes

Disclosure: The authors report no conflicts of interest.

References

1. Winder DG, Sweatt JD. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nature Rev Neurosci. 2001;2:461–474. [PubMed]
2. Izquierdo I, Bevilaqua LRM, Rossato JI, Bonini JS, Medina JH, Cammarota M. Different molecular cascades in different sites of the brain control consolidation. Trends Neurosci. 2006;29:496–505. [PubMed]
3. Cammarota M, Bernabeu R, Levi de Stein M, Izquierdo I, Medina JH. Learning-specific, time-dependent increases in hippocampal Ca2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity. Eur J Neurosci. 1998;10:2669–2676. [PubMed]
4. Bevilaqua LR, Medina JH, Cammarota M, Izquierdo I. Memory consolidation induces N-methyl-d-aspartic acid receptor and Ca(2+)/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties. Neurosci. 2005;136:397–403. [PubMed]
5. Bernabeu R, Bevilaqua L, Ardenghi P, Bromberg E, Schmitz P, Bianchin M, Izquierdo I, Medina JH. Involvement of hippocampal D1/D5 receptor - cAMP signaling pathways in a late memory consolidation phase of an aversively-motivated task in rats. Proc Natl Acad Sci USA. 1997;94:7041–7046. [PubMed]
6. Samuels IS, Karlo JC, Faruzzi AN, et al. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J Neurosci. 2008;28:6983–6995. [PMC free article] [PubMed]
7. Schrader LA, Ren Y, Cheng F, Bui D, Sweatt JD, Anderson AE. Kv4.2 is a locus for PKC and ERK/MAPK cross-talk. Biochem J. 2009;417:705–715. [PMC free article] [PubMed]
8. Paratcha G, Furman M, Bevilaqua L, et al. Involvement of hippocampal PKCbI isoform in the early phase of memory formation of an inhibitory avoidance learning. Brain Res. 2000;855:199–205. [PubMed]
9. Holahan M, Routtenberg A. The protein kinase C phosphorylation site on GAP-43 differentially regulates information storage. Hippocampus. 2008;18:1099–1102. [PMC free article] [PubMed]
10. Riedel G, Platt B. From messengers to molecules. New York: Kluwer Academic; 2004. pp. 614–614.
11. Zhao W, Bennett P, Sedman GL, Ng KT. The impairment of long-term memory formation by the phosphatase inhibitor okadaic acid. Brain Res Bull. 1995;36:557–561. [PubMed]
12. Bennett PC, Moutsoulas P, Lawen A, Perini E, Ng KT. Novel effects on memory observed following unilateral intracranial administration of okadaic acid, cyclosporine A, FK506 and [VeVal4]CyA. Brain Res. 2003;988:56–68. [PubMed]
13. Mansuy IM, Shenolikar S. Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends Neurosci. 2006;29:679–686. [PubMed]
14. Stefan MI, Edelstein SJ, Le Novère N. An allosteric model of calmodulin explains differential activation of PP2B and CaMKII. Proc Natl Acad Sci USA. 2008;105:10768–10773. [PubMed]
15. Wang LY, Orser BA, Brautigan DL, MacDonald JF. Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature. 1994;369:230–232. [PubMed]
16. Woo NH, Nguyen PV. Silent metaplasticity of the late phase of long-term potentiation requires protein phosphatases. Learn Mem. 2002;9:202–213. [PubMed]
17. Gruart A, Muñoz MD, Delgado-García JM. Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J Neurosci. 2006;26:1077–1087. [PubMed]
18. Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science. 2006;313:1093–1097. [PubMed]
19. Bennett PC, Zhao W, Lawan A, Ng KT. Cyclosporin A, an inhibitor of calcineurin, impairs memory formation in day-old chicks. Brain Res. 1996;730:107–117. [PubMed]
20. Sun L, Liu SY, Zhow XW, Wang XC, Liu R, Wang Q, Wang JZ. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neurosci. 2003;118:1175–1182. [PubMed]
21. Bennett PC, Zhao W, Ng KT. Concentration-dependent effects of protein phosphatases (PP) inhibitors implicate PP1 and PP2A in different stages of memory formation. Neurobiol Learn Mem. 2001;75:91–110. 22. [PubMed]
22. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell. 1998;92:25–37. [PubMed]
23. Mansuy IM, Mayford M, Jacob B, Kandel ER, Bach ME. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell. 1998;92:39–39. [PubMed]
24. Malleret G, Haditsch U, Genoux D, et al. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of Calcineurin. Cell. 2001;104:675–686. [PubMed]
25. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM. Protein phosphatase 1 is a molecular constraint on learning and memory. Nature. 2002;418:929–930. [PubMed]
26. Jouvenceau A, Hédou G, Potier B, Kollen M, Dutar P, Mansuy IM. Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci. 2006;24:564–572. [PubMed]
27. Izquierdo I, Barros DM, Mello e Souza T, Souza MM, Izquierdo LA, Medina JH. Mechanisms for memory types differ. Nature. 1998;393:635–636. [PubMed]
28. McGaugh JL. Memory: a century of consolidation. Science. 2000;287:248–251. [PubMed]
29. Cohen P, Alemany S, Hemmings BA, Resink TJ, Strålfors P, Tung HY. Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Meth Enzymol. 1988;159:390–408. [PubMed]
30. Grahame-Hardie D. Protein phosphorylation: a practical approach. Oxford Academic Press; Oxford: 1999.
31. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press; San Diego: 1986.
32. Vianna MR, Alonso M, Viola H, et al. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem. 2000;7:333–340. [PubMed]
33. Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience. 1995;69:691–698. [PubMed]
34. Silva AJ, Josselyn SA. The molecules of forgetfulness. Nature. 2002;418:929–930. [PubMed]
35. Izquierdo I. A arte de esquecer. Rio de Janeiro: Vieira & Lent; 2004.
36. Lopez-Salon M, Alonso M, Vianna MR, Viola H, Mello e Souza T, Izquierdo I, Pasquini JM, Medina JH. The ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci. 2001;14:1820–1826. [PubMed]

Articles from Dementia & Neuropsychologia are provided here courtesy of Association of Cognitive and Behavioral Neurology